These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 3786923)
1. [Does chemotherapy bring real benefit to patients with inoperable bronchial epidermoid cancer?]. Depierre A Rev Mal Respir; 1986; 3(4):169-71. PubMed ID: 3786923 [No Abstract] [Full Text] [Related]
2. Chemotherapy of inoperable bronchogenic carcinoma. Behera D; Malik SK Indian J Chest Dis Allied Sci; 1985; 27(3):175-89. PubMed ID: 3017850 [No Abstract] [Full Text] [Related]
3. Hexamethylmelamine in inoperable bronchogenic carcinoma. Takita H N Y State J Med; 1972 Feb; 72(4):477-80. PubMed ID: 4334448 [No Abstract] [Full Text] [Related]
4. [Prognostic factors in the chemotherapy of bronchial cancers]. Alberto P Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755 [No Abstract] [Full Text] [Related]
5. [Cytostatic therapy of tumors of the lung]. De Marco F; Saviano G; Tenore G Arch Monaldi; 1974; 29(3-4):326-35. PubMed ID: 4463917 [No Abstract] [Full Text] [Related]
6. [Selective bronchial artery perfusion with cisplatin in the treatment of inoperable bronchogenic carcinoma]. Liu ZJ Zhonghua Fang She Xue Za Zhi; 1987 Feb; 21(1):4-7. PubMed ID: 2954790 [No Abstract] [Full Text] [Related]
7. Clinical evaluation of an innoxious antineoplastic agent: preliminary study of 106 patients treated with or without RSV after pulmonary resection for bronchogenic carcinoma. Hansen JL Cancer Chemother Rep 3; 1973 Mar; 4(2):261-4. PubMed ID: 4729327 [No Abstract] [Full Text] [Related]
8. Chemotherapy for lung cancer at the Institute of Experimental and Clinical Oncology, Academy of Medical Sciences, USSR. Perevodchikova NI; Bychkov MB Cancer Chemother Rep 3; 1973 Mar; 4(2):251-5. PubMed ID: 4199645 [No Abstract] [Full Text] [Related]
9. [Status of chemotherapy in inoperable non-small cell bronchial carcinoma]. Brunner KW; Joss R; Goldhirsch A Schweiz Rundsch Med Prax; 1983 Aug; 72(32):1057-62. PubMed ID: 6622423 [No Abstract] [Full Text] [Related]
10. Phase II study of the effect of methyl-CCNU (NSC-95441) on bronchogenic carcinoma. Takita H; Brugarolas A; Mittelman A; Vincent R Cancer Chemother Rep 3; 1973 Mar; 4(2):257-9. PubMed ID: 4125743 [No Abstract] [Full Text] [Related]
11. Clinical evaluation of procarbazine and fluorouracil in advanced lung cancer. Pacilio G; Puzziello T Bronches; 1971; 21(4):402. PubMed ID: 4340778 [No Abstract] [Full Text] [Related]
12. [Palliative treatment with chemical agents in far advanced bronchial cancer]. Zelechowska A Gruzlica; 1968 Oct; 36(10):912-5. PubMed ID: 4179493 [No Abstract] [Full Text] [Related]
15. [Treatment of lung cancer by a cooperative group: EORTC Lung Cancer Working Party (Belgium)]. Klastersky J; Sculier JP Rev Med Brux; 1983 Sep; 4(7):485-9. PubMed ID: 6316462 [No Abstract] [Full Text] [Related]
16. [Symptomatology of the inoperable and irradiable bronchial carcinoma]. Hammer O Med Welt; 1968 Jun; 26():1560-3. PubMed ID: 5718811 [No Abstract] [Full Text] [Related]
17. Antitumor drugs in inoperable lung cancer. Behera D; Malik SK Indian J Chest Dis Allied Sci; 1984; 26(1):60-1. PubMed ID: 6510992 [No Abstract] [Full Text] [Related]
18. Chemotherapy as an adjunct to surgery in the treatment of pulmonary malignant disease. Mountain CF Acta Chir Belg; 1971 Apr; 70(4):351-64. PubMed ID: 5143081 [No Abstract] [Full Text] [Related]
19. [Immunorestoration in epidermoid cancer of the bronchi. Therapeutic results (proceedings)]. Pouillart P; Palangie T; Jouve M; Huguenin P; Gautier H; Morin P; Baron A J Radiol Electrol Med Nucl; 1978 Nov; 59(11):654-7. PubMed ID: 748546 [No Abstract] [Full Text] [Related]